Covance bolsters pharmacovigilance services with Sciformix acquisition

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/marchmeena29)
(Image: Getty/marchmeena29)
Covance has acquired Sciformix in a deal that augments the CRO’s pharmacovigilance capabilities for post-approval safety solutions and expands its global footprint.

Covance, LabCorp’s contract research organization (CRO) business, has acquired Sciformix Corporation, a scientific process outsourcing company focused on pharmacovigilance and regulatory solutions.

“Sciformix enhances Covance’s offering, particularly in post-approval pharmacovigilance. Its capabilities are complementary with Covance’s existing Drug and Device Safety Solutions and Adjudication as well as Covance Market Access (CMA),”​ Sue Maynard, vice president, corporate communications, LabCorp, told Outsourcing-Pharma.com.

Sciformix provides post-marketing safety and risk management, clinical development support services, regulatory affairs and operations, technology services, and real-world evidence (RWE) solutions.

Maynard said: “The need for post-approval solutions is driven by many factors including momentum in new product launches, and increasing expectations for safety monitoring during later stages of development and post approval.”

Sciformix – which Maynard said will “largely operate as an independent business unit”​ – has 1,100 employees are based in Asia, further expanding Covance’s global footprint.

Terms of the transaction were not disclosed.

Related news

Show more

Related products

show more

Next generation ePRO from SQN Health

Next generation ePRO from SQN Health

In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...

baxter_bloomington_facility_larger

Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.

lyo_development

Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Related suppliers

Follow us

Products

View more